Latest Ishita Drugs & Indus stock price
Ishita Drugs & Indus P/E Ratio
ISHITADR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
25.9
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
25.9
Current Price
₹75.10
EPS (TTM)
₹2.90
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.4
Sector Median
31.12
Sector Rank
#11 of 132
Sector Percentile
8.3%
Key P/E Ratio Insights for Ishita Drugs & Indus
- Stock appears overvalued with PE of 25.9, suggesting caution for new investments
- Trading at discount to sector average PE of 53.4
View the ISHITADR equity price for detailed stock performance.
Related Pages for Ishita Drugs & Indus
Additional stock information and data for ISHITADR
Sector P/E Ratio Comparison
Comparing Ishita Drugs & Indus with other companies in Healthcare sector
Sector Average
53.4
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
132
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |